TYK Medicines, Inc (HKG:2410)
Hong Kong · Delayed Price · Currency is HKD 12.80
+0.13 (1.03%)
Feb 13, 2026, 4:08 PM HKT
TYK Medicines Market Cap
TYK Medicines has a market cap or net worth of 4.82 billion as of February 13, 2026. Its market cap has decreased by -47.00% in one year.
Market Cap
4.82B
Enterprise Value
4.57B
Revenue
117.25K
Ranking
n/a
PE Ratio
n/a
Stock Price
12.80
Market Cap Chart
Since August 20, 2024, TYK Medicines's market cap has decreased from 5.08B to 4.82B, a decrease of -5.22%. That is a compound annual growth rate of -3.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 4.82B | -3.36% |
| Dec 31, 2025 | 4.98B | -71.50% |
| Dec 31, 2024 | 17.48B | 244.16% |
| Aug 20, 2024 | 5.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mirxes Holding Company | 6.67B |
| Ocumension Therapeutics | 5.63B |
| Laekna | 5.12B |
| Viva Biotech Holdings | 4.98B |
| Shandong Boan Biotechnology | 4.82B |
| Jacobio Pharmaceuticals Group | 4.72B |
| Beijing Luzhu Biotechnology | 4.56B |
| Qyuns Therapeutics | 4.45B |